Evidence map›Paper›PMID 26435700›Full record

ArticleJournal of inflammation (London, England)2015

Obesity-associated hypertension is ameliorated in patients with TLR4 single nucleotide polymorphism (SNP) rs4986790.

Simon Schneider, Petra Hoppmann, Werner Koch, Stephan Kemmner, Christoph Schmaderer, Lutz Renders, Adnan Kastrati, Karl-Ludwig Laugwitz, Uwe Heemann, Marcus Baumann

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. TT Genotype ofNutrients · 2023
    Article
  2. Review
  3. Genes · 2020
    Article
  4. Immune mechanisms of hypertension.Nature reviews. Immunology · 2019
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Simon Schneider *I. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Petra HoppmannI. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Werner KochDeutsches Herzzentrum München, Technical University Munich, Munich, Germany.
Stephan KemmnerDepartment of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger St. 22, 81675 Munich, Germany.
Christoph SchmadererDepartment of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger St. 22, 81675 Munich, Germany.
Lutz RendersDepartment of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger St. 22, 81675 Munich, Germany.
Adnan KastratiDeutsches Herzzentrum München, Technical University Munich, Munich, Germany.
Karl-Ludwig LaugwitzI. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Uwe HeemannDepartment of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger St. 22, 81675 Munich, Germany.
Marcus Baumann *Department of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger St. 22, 81675 Munich, Germany.
Klinikum rechts der Isar · DEGerman Centre for Cardiovascular Research · DEDeutsches Herzzentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity is strongly associated with hypertension. Despite numerous mechanistic links the association is not fully understood. Western diet increases uptake of Toll-Like receptor 4 (TLR4) ligands such as free fatty acids or endotoxin. We recently demonstrated that TLR4 ligands are involved in the development of hypertension. We hypothesized that TLR4 ligands are involved in obesity-associated hypertension and investigated the TLR4 single nucleotide polymorphism (SNP rs 498790). This SNP is frequent, associated with cardiovascular disease and characterized by blunted response upon exposure to TLR4 ligands.

methodsWe investigated 3657 patients undergoing coronary angiography. Blood pressure was determined in standardized manner prior angiography. The diagnosis of hypertension was based on record data. Patients were characterized for TLR4 single nucleotide polymorphism (SNP) rs4986790. Patients were stratified according to quartiles of Body mass index (BMI) and according to the polymorphism. The association between the TLR4 polymorphism and blood pressure in obese patients (BMI > 30 kg/m(2)) was investigated by multivariate regression analysis.

resultsOut of 3657 patients 3017 patients fulfilled inclusion criteria. In the whole cohort a significant increase of SBP, pulse pressure and diagnosis of hypertension was observed across BMI quartiles. By contrast, no significant increase of SBP, pulse pressure or diagnosis of hypertension was observed in the 319 cases with TLR4 SNP rs4986790 across BMI quartiles. These obese cases had significantly lower SBP, lower pulse pressure (7.0 and 7.6 mmHg) and less diagnosis of hypertension as controls. In obesity the TLR4 SNP rs4986790 was an independent predictor of SBP.

conclusionSystolic blood pressure increase with obesity was blunted in cases with TLR4 SNP rs4986790.

Indexed as

GeneticsObesity associated hypertensionSystolic blood pressureTLR4Toll-like receptor 4

Identifiers

PMID26435700
PMCPMC4591702
OpenAlexW2152700769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.